asthma medications



dynaCERT Inc.
Latest Comments
image_pdfimage_print

Steve Saviuk on Valeo Pharma’s TSX Listing and Q1-22 revenues of $4.2 million, up 128% over Q1-21

In a recent InvestorIntel interview, Tracy Weslosky interviews Valeo Pharma Inc.’s (TSX: VPH | OTCQB: VPHIF) Founder, CEO and Director […]


Valeo Pharma is cashed up and ready to expand as COVID restrictions end

Are we starting to see the beginning of the end of COVID’s reign of terror over humanity? I certainly hope […]